Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Germany Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20043
20055
20065
20076
20083
20091
20108
20112
20126
20133
20148
20152
20165
20172
20182
20191
20202
20213
20223
20231
20242
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Terminated9
Recruiting8
Unknown status7
Active, not recruiting6
No longer available1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals29
Bristol-Myers Squibb9
European Society for Blood and Marrow Transplantation4
Pfizer4
Fred Hutchinson Cancer Center3
Gruppo Italiano Malattie EMatologiche dell'Adulto3
University of Jena3
Ariad Pharmaceuticals2
European LeukemiaNet2
Teva Branded Pharmaceutical Products R&D, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive87
Leukemia17
Leukemia, Myeloid, Chronic-Phase13
Precursor Cell Lymphoblastic Leukemia-Lymphoma9
Philadelphia Chromosome8
Blast Crisis6
Leukemia, Myeloid6
Myeloproliferative Disorders6
Bone Marrow Diseases5
Leukemia, Myeloid, Acute5

Trials

Showing 1 to 25 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.